Rubraca
Term · Oncology and biomedicine · MLC-T-ONC-007518
A drug used to treat adults with certain types of prostate cancer or ovarian epithelial, fallopian tube, or primary peritoneal cancer. It is also being studied in the treatment of other types of cancer. Rubraca blocks an enzyme involved in many cell functions, including the repair of DNA damage. Blocking this enzyme may help keep cancer cells from repairing their damaged DNA, causing them to die. Rubraca is a type of PARP inhibitor. Also called AG014699, PARP-1 inhibitor AG014699, and rucaparib camsylate.
| Identifier | MLC-T-ONC-007518 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | AG014699; PARP-1 inhibitor AG014699; rucaparib camsylate |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-007518",
"term": "Rubraca",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat adults with certain types of prostate cancer or ovarian epithelial, fallopian tube, or primary peritoneal cancer. It is also being studied in the treatment of other types of cancer. Rubraca blocks an enzyme involved in many cell functions, including the repair of DNA damage. Blocking this enzyme may help keep cancer cells from repairing their damaged DNA, causing them to die. Rubraca is a type of PARP inhibitor. Also called AG014699, PARP-1 inhibitor AG014699, and rucaparib camsylate.",
"synonyms": [
"AG014699",
"PARP-1 inhibitor AG014699",
"rucaparib camsylate"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/rubraca/"
}
Record 14,606 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.